## Abstract Two benzodiazepine CCK antagonists __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H 1,4‐benzodiazepin‐3‐yl)‐benzamide **2** and __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H‐1,4‐benzodiazepin‐3‐yl)‐[^14^C]methyl‐benzamide **3** were synthesized in high yields through the reac
The synthesis of the 14C and 2H-isotopomers of (R)-N-[2-(2′-ethoxyphenoxy)-ethyl]-N-2-[3-(4′-methoxy-3′-sulfonamido)-phenyl]-propylamine hydrochloride, an α1-adrenoreceptor antagonist
✍ Scribed by William J. Wheeler; Klaus K. Schmiegel; David C. Hunden
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 552 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
The synthesis of [14C]-and [2H]-labeled LY253351 (YM12617-I), a potent a,-receptor antagonist, which is potentially useful in the treatment of benign prostatic hypertrophy (BPH) is described. The [14C]-isotopomer was synthesized from [14C]-potassium cyanide in nine steps in 1.5% radiochemical yield. One of the key intermediates, [14C]-4-methoxyphenylacetone, was synthesized from [14C]-4-methoxyphenylacetyl chloride by a Pd(0)-catalyzed reaction with tetramethylstannane. The [2H]-labeled material was synthesized by a Pd/C catalyzed reductive amination with deuterium gas.
📜 SIMILAR VOLUMES
The partial ergoline LY228729 (1) which was a potent 5HT 1A agonist has been studied clinically. Somewhat later, a related analog, (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine (2a) which in addition to potent 5HT 1A agonist activity was a muscarinic antagonist, was chosen
The compound 6-chloro-2,3,4,5-tetrahydroi~-methyl-l &3-t#nzazepine (SK&F 86466) was prepared in phenyl-U-C and phenyl-C , labeled forms in a six step sequence beginning with the appropriately labeled benzenes. In addition, the N-desmeJhyl analog of the carbon-1 4 labeled isotopomer and the N-methyl-
Molecular imaging and quantification of myocardial b 1 -adrenoceptor (AR) rather than total b-AR density is of great clinical interest since cardiac biopsy studies suggest that myocardial b 1 -AR density is reduced in patients with chronic heart failure whereas cardiac b 2 -AR density may vary. Posi
## Abstract Reaction of isonicotinic [^14^C] acid hydrazide (**1**) with the Zinke salt (**2**) afforded N‐(4‐pyridyl [^14^C] carbonylimino)pyridinium ylide (**3**) in 81% chemical yield. Sodium borohydride reduction of **3** gave N‐(4‐pyridyl [^14^C] carbonylamino) −1,2,3,6‐tetrahydropyridine (**4